Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro. - sprookjes - yvandenbroek - TriplyDB

Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.

Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.

http://www.wikidata.org/entity/Q33935329

about

CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines Cytomegalovirus antivirals and development of improved animal models Prodrugs of phosphonates and phosphates: crossing the membrane barrier Current and potential treatments for ubiquitous but neglected herpesvirus infections Seco-pregnane steroids target the subgenomic RNA of alphavirus-like RNA viruses Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus Human cytomegalovirus induces TGF-β1 activation in renal tubular epithelial cells after epithelial-to-mesenchymal transition.Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein.Development of CMX001 for the Treatment of Poxvirus Infections.Alkoxyalkyl esters of (S)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro.Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate.Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.Progress in the development of new therapies for herpesvirus infections Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoesters Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12 Update on new antivirals under development for the treatment of double-stranded DNA virus infections Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection.Synthesis and antiviral activity of certain second generation methylenecyclopropane nucleosides Human cytomegalovirus UL97 kinase alters the accumulation of CDK1.Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control?Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivo.Treatment of herpes simplex virus infections in pediatric patients: current status and future needs.Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.How we treat cytomegalovirus in hematopoietic cell transplant recipients.Human herpesvirus 6 U69 kinase phosphorylates the methylenecyclopropane nucleosides cyclopropavir, MBX 2168, and MBX 1616 to their monophosphates.Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.How I treat adenovirus in hematopoietic stem cell transplant recipients The search for new therapies for human cytomegalovirus infections.Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.Prodrug strategies in ocular drug delivery.Anti-herpesvirus agents: a patent and literature review (2003 to present).The development of new therapies for human herpesvirus 6.Helicase-primase as a target of new therapies for herpes simplex virus infections.

P2860

Q24599841-D03A7FF5-3628-481E-901E-C733B341F8BA Q24629979-053EE5EA-226A-4612-8AF4-6747BB3A3F6D Q26745838-558C6A7C-1D39-47CA-9DCB-693F04EE2DD2 Q27000998-DD6AFD0D-3CE5-4BD8-9CF5-C2FBE52FE80C Q27005712-9CD0EC6E-8F58-4B11-9687-4560446BFEE6 Q27023452-02D8C5F5-53D5-44D2-A77B-3F6B1EA43A8F Q27478419-A6DACB02-9B51-4E71-A978-79993E1D5963 Q27489390-280733A3-8DF9-4C69-AB39-3B90B0B63F98 Q33747809-EABE6519-CE29-4FA0-895E-4E39D300E064 Q34397766-27EBD0CB-F38B-4472-828A-18B7E8B590D9 Q34801704-E5770EE8-F3AD-4D25-A0E9-08FAD85D2104 Q34973723-2364562C-B0FF-4B60-BC7F-DA37A6E5452F Q35260316-72E9A128-AD4C-4C78-B0FE-DDBFCF1B76DD Q35270303-632DDDFE-0891-4D8E-A6E0-FDA35299BB06 Q35270714-27D7EEE5-4D5D-43A8-8378-FDBBE4A89884 Q35531731-CA86B857-76D8-466F-9824-2E44705C2F63 Q35590695-748807D4-6732-4CF0-B3CC-FB2B8B9525FC Q35636006-D03C4BB9-B600-4C26-9B90-D9022C157F8F Q35768296-5BA7B1E8-B49A-4748-A203-2A7DCC77D654 Q35943736-81598B5F-BC5D-4112-98AB-13E6FC9464C3 Q36185647-2FDFB27E-44DE-4CFF-94F4-177A4C99990B Q36324846-3BED147E-FC59-4757-B51F-5A58E1AF74FF Q36433206-B4AEF59E-696F-4BE5-8638-BF29DD68ECE7 Q36523126-77E0E238-9F57-41FF-9522-5B29A653DF89 Q36688962-7B4633A0-2EDC-4D7C-84C4-3EC03214BED3 Q36804032-08D2EED0-4859-45E3-967B-3B1F8D60EF32 Q36938445-20513869-8C51-4879-94B4-0235A9D92C84 Q36969798-72692D5A-CDEB-48FE-9ECD-C6FF4790E749 Q37173390-EF66235D-C792-4AF3-8DE2-A18150305E0D Q37237427-EA0BFFE5-6A0B-4FDE-B4D1-314D2C20DE2B Q37263407-B2FBCCD0-47D2-40EA-B30E-CBEFF59B948A Q37401749-28C2E44C-3FD1-4549-8123-49D971752F6E Q37450711-EFA8A96E-BD02-4212-85B6-D43364B9F8EB Q37788461-077EFF02-CF89-4B31-B7F1-1FEBD382211F Q37811458-0B35310C-6E4F-4D7D-98D4-B369FB81543E Q37951633-BCE7E386-481F-4381-A28C-B8418CA4EC3F Q38005228-9E8686F2-37D9-4BD3-B53C-3D08FB98F0AA Q38228015-78130433-BA7A-44DA-8355-FADC860670B3 Q38280949-23AFD88D-D880-43B5-B048-C96C3F06A892 Q38351481-82E35BB9-55E4-4554-AC57-31DF99F1334B

P2860

Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.

http://www.wikidata.org/entity/Q33935329

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Comparative activities of lipi ...... ion of herpesviruses in vitro.

@ast

Comparative activities of lipi ...... ion of herpesviruses in vitro.

@en

type

label

Comparative activities of lipi ...... ion of herpesviruses in vitro.

@ast

Comparative activities of lipi ...... ion of herpesviruses in vitro.

@en

prefLabel

Comparative activities of lipi ...... ion of herpesviruses in vitro.

@ast

Comparative activities of lipi ...... ion of herpesviruses in vitro.

@en

P1433

Q33935329-DA9A5EC2-88BD-4FB4-B99B-50C02F209832

P1476

Q33935329-35D58863-4A7A-4988-979C-8BF83F40164F

P2093

Q33935329-013B6E9E-FFDF-4B26-B495-20EF0976B486

Q33935329-2315DA68-C72A-4712-A347-6B38A9141DF5

Q33935329-53A08709-8FED-4EA4-BC2B-26481B8B42A3

Q33935329-66CFDA14-DBE4-4F86-8A7E-E48122F72422

Q33935329-79262419-685D-4F5D-9AE8-6E1D3E7BFFAD

Q33935329-7D1B1A69-AA3B-4086-AF58-BD054EBB61CB

Q33935329-82534215-79DD-43FF-9D03-2A9E7029DC36

Q33935329-AC544A9A-EB84-487E-B336-C974AF8EE493

Q33935329-B4442A24-A2E5-40FA-A861-70D16159C424

Q33935329-BA24841A-CBC7-4EC3-A5A1-38B7AFEA1C54

P2860

Q33935329-0194AA72-1C34-46D6-8AE8-39D5F493F9B3

Q33935329-06021F3D-58FE-44BC-9F62-62F000822D76

Q33935329-0B13585A-1A6B-4CC5-8675-7A366BA05F59

Q33935329-0B2B3270-DE9E-42AB-82A7-647B89C4D7D0

Q33935329-10CCE863-BA03-41EF-851C-6BC03A166263

Q33935329-13F92CA0-C460-423D-8A72-45597C38DED4

Q33935329-14297A5C-6D2F-4C4D-80AD-27001A5F6B8A

Q33935329-15B33B99-5660-4D0F-A037-0B034B274336

Q33935329-2D5D4756-9C21-419C-B1DA-A62D88CB36C5

Q33935329-342C67A5-CA59-4ACB-A045-E7660DF01271

P304

Q33935329-A489971A-138A-4E92-ADC9-875C986F674E

P31

Q33935329-13DE6D8F-E0AC-40E6-A6F6-00E2023F4B9D

P356

Q33935329-49279906-0796-47E8-B00D-6F43A2CE78CA

P407

Q33935329-49A1496B-8592-4544-A0E4-CAC63681BF11

P433

Q33935329-E2CC5662-E523-41DB-82F4-BBFC81857ACB

P478

Q33935329-BDDB437E-4ED2-4E93-8893-5836755AF0BE

P577

Q33935329-BABE91CD-E751-41A7-852E-7A8BDE21E1CF

P5875

Q33935329-64604327-11DB-404D-9F16-BC33A8C71FC4

P698

Q33935329-0DA1CDA5-DDDE-4D76-8336-99309C49849E

P932

Q33935329-ACD1D030-F7A5-45BC-9BFD-E11EB1935AD1

P356

AAC.49.9.3724-3733.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Comparative activities of lipi ...... ion of herpesviruses in vitro.

@en

P2093

Caroll B Hartline

http://www.w3.org/2001/XMLSchema#string

Earl R Kern

http://www.w3.org/2001/XMLSchema#string

Emma A Harden

http://www.w3.org/2001/XMLSchema#string

James R Beadle

http://www.w3.org/2001/XMLSchema#string

Karl Y Hostetler

http://www.w3.org/2001/XMLSchema#string

Mark N Prichard

http://www.w3.org/2001/XMLSchema#string

Nicole L Kushner

http://www.w3.org/2001/XMLSchema#string

Shannon L Daily

http://www.w3.org/2001/XMLSchema#string

Stephanie L Williams-Aziz

http://www.w3.org/2001/XMLSchema#string

W Brad Wan

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infections

Antiviral drug susceptibility of human herpesvirus 8

Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.

Resistance of human cytomegalovirus to antiviral drugs.

Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

Clinical uses of cidofovir.

Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infection

Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir

Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro

P304

3724-3733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.9.3724-3733.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7633884

http://www.w3.org/2001/XMLSchema#string

P698

16127046

http://www.w3.org/2001/XMLSchema#string

P932

1195409

http://www.w3.org/2001/XMLSchema#string